Wikidata

(Q57636890)

English

Treatment of chronic myelogenous leukemia with interferon alfa-2c: response rate and toxicity in a phase II multicenter study. The Austrian Biological Response Modifier (BRM) Study Group

article

In more languages

Statements

title
Treatment of chronic myelogenous leukemia with interferon alfa-2c: response rate and toxicity in a phase II multicenter study. The Austrian Biological Response Modifier (BRM) Study Group (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8235697
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8235697%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 October 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q57636890&oldid=1263377367"